PATENT CLAIM ANALYSIS

Application Number: 16273926
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["702", "019000"]

Abstract:
A method of administering insulin includes receiving blood glucose measurements of a patient at a data processing device from a glucometer. The blood glucose measurements are separated by a time interval. The method also includes receiving patient information at the data processing device and selecting a subcutaneous insulin treatment from a collection of subcutaneous insulin treatments. The selection is based on the blood glucose measurements and the patient information. The selection includes one or more of a subcutaneous standard program, a subcutaneous program without meal boluses, a meal-by-meal subcutaneous program without carbohydrate counting, a meal-by-meal subcutaneous program with carbohydrate counting, and a subcutaneous program for non-diabetic patients. The method also includes executing, using the data processing device, the selected subcutaneous insulin treatment.

Claim (Index 1):
A method comprising:\n receiving, at data processing hardware, a glucose measurement of a patient; determining, by the data processing hardware, a glucose type of the received glucose measurement; and when the determined glucose type comprises one of a pre-lunch glucose measurement or a pre-dinner glucose measurement:\n obtaining, by the data processing hardware, a previous Carbohydrate-to-Insulin Ratio (CIR) for an immediately previous meal consumed by the patient, the immediately previous meal consumed by the patient comprising one of breakfast when the determined glucose type comprises the pre-lunch glucose measurement or lunch when the determined glucose type comprises the pre-dinner glucose type; \n adjusting, by the data processing hardware, the previous CIR for the immediately previous meal consumed by the patent based on the received glucose measurement; and \n determining, by the data processing hardware, a recommended meal bolus for the determined glucose type based on the adjusted previous CIR, the recommended meal bolus corresponding to an insulin dose of rapid-acting insulin to be administered to the patient at the time of day associated with the determined glucose type to bring and maintain the patient's glucose level into a target range.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 99.0
- Lexical Diversity: 2.35088
- Patent Class: 702.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15342606', '15942740', '14938997', '14524918', '14922763']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.398365995721033
- 35 USC 102 Novelty (BERT): 0.7504262914312695
- Combined Prediction Score: 0.4335720252920566
- Mean Citation Score: 793.101326
- Max Citation Score: 824.6608
- Similarity Product: 791.133808011055

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test